key: cord-0726686-m4v0vumx
authors: Yadav, Satya Prakash
title: Impact of COVID19 on Children with Blood and Cancer Disorders
date: 2022-05-26
journal: nan
DOI: 10.1016/j.phoj.2022.05.008
sha: e7b6e8fbd36dbab53466b0adb0f9a4020a81aeba
doc_id: 726686
cord_uid: m4v0vumx

nan

Covid19 pandemic has altered the world we live in for forever. It has proved fatal for so many people globally and caused morbidity in millions. Coming to children with blood and cancer disorders; we all had no idea how will this immunocompromised population handle this new virus (1) . Pediatric Hematology Oncology (PHO) chapter of Indian Academy of Pediatrics (IAP) brought out timely guidelines on how to run PHO services during COVID19 pandemic (2) . Pandemic tested our ability to manage these immunocompromised children safely and provide them timely appropriate therapy for the underlying disorder. Lockdowns dented accessibility of care and need for isolation facilities for COVID19 patients further complicated care of PHO patients.

In this special issue focussed on COVID19 in PHO we have been able to get first glimpse of here MIS-C post BMT in 2 children of whom one died (8) . Another case of MIS-C has been reported in a child with acute myeloid leukemia during induction chemotherapy (9) . Post COVID19 MIS-C was reported in another child with thalassemia post BMT (7) . Three other children developed MIS-C and recovered with supportive care (5). It's quite surprising that children post BMT or AML therapy were very immune-suppressed yet they are able to mount such severe inflammatory response post COVID19. In another study, although MIS-C is not J o u r n a l P r e -p r o o f mentioned as a diagnosis but steroids were given to 7/17 (41.1%) patients. Six patients were given steroids as the inflammatory markers were high and all recovered (4) .

in this issue few reports have described this aspect also (4) (5) (6) (7) (8) (10) (11) (12) . Kakkar et al. have reported a cohort of 14 patients with thalassemia and COVID19 patients of whom only 2 needed hospitalisation. The underlying diagnosis of transfusion-dependent thalassemia did not lead to excess morbidity and mortality (10) . Authors also highlighted that older thalassemia patients and those with co-morbidities had higher risk of mortality due to covid19. One child with Sickle cell disease post BMT developed COVID19 and recovered uneventfully (4) .

Although data on sickle cell disease and COVID19 is sparse from India but Covid19 can lead to significant morbidity and mortality especially in older patients of sickle cell disease.

Data on COVID19 in children with inborn error of immunity (IEI) is scarce. Yadav et al. report 2 cases of mild COVID19 in a cohort of 31 children with IEI (11). Authors discuss various published studies and propose that COVID19 may have varied presentation and outcome in different types of IEI and more data needs to be captured. Another study reported a child with familial hemophagocytic lympho histiocytosis (HLH) and COVID19 who developed MIS-C and coronary artery dilatation but recovered fully (5) . In another report impact of COVID19 in

COVID-19 in Children with Blood and Cancer Disorders: What Do We Know So Far?

Guidance for Pediatric Hematology-Oncology (PHO) and

Hematopoietic Stem Cell Transplant Services during COVID-19 Pandemic: A Consensus Statement by PHO Chapter of Indian Academy of Pediatrics

Outcomes of COVID-19 in children with cancer -Report from the Indian Pediatric Oncology Group (InPOG) COVID-19 registry in India

Second wave of COVID-19 -Not a matter of great concern for pediatric hematologist/oncologist

Covid-19 in pediatric hematology-oncology and stem cell transplant patients -The spectrum of illness, complications and comparison of first two waves

COVID-19 in children with blood and cancer disorders: An experience from India

The impact of COVID-19 in children post hematopoietic stem cell transplantation: Experience from a pediatric transplant unit in India

Post COVID-19 multisystem inflammatory syndrome in children undergoing hematopoietic stem cell transplant

Acute myeloid leukemia complicated by post COVID-19 multi-system inflammatory syndrome-children

Home isolation in transfusion-dependent thalassemia patients with SARS CoV2 infection: Experience from a developing country

Milder COVID-19 in children with inborn errors of immunity

COVID-19 in children with severe aplastic anemia